FDA approved Imfinzi with gemcitabine and cisplatin for muscle-invasive bladder cancer, based on NIAGARA trial results showing improved survival outcomes. The regimen integrates immunotherapy in pre- ...

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial. Previous data showed that in the phase 3 JAVELIN ...

Cystectomy often treats bladder cancer. But bladder removal surgery can help other bladder problems, too. After cystectomy, your urine may need a new route to exit your body (urinary diversion).

Johnson & Johnson's confidence in its bladder cancer therapy TAR-200 – dented by a negative phase 3 readout last year – seems to be justified. New data from the SunRISe-1 study of TAR-200 in ...

Results from the Phase IIb SunRISe-1 study demonstrated a one-year duration of response with the TAR-200 intravesical gemcitabine-releasing system in patients with Bacillus ...

Oral presentation provides update from QUILT-3.032 on durable complete responses to ANKTIVA ® plus BCG in BCG-unresponsive non-muscle invasive bladder cancer carcinoma in situ (NMIBC CIS ...

high-risk non-muscle invasive bladder cancer "Patients with bladder cancer need more effective treatment options that are both tolerable and easily incorporated into everyday practice, especially ...

The main symptom of bladder cancer is blood in your urine. This is the same for both men and women. Bladder cancer symptoms to look out for: blood in the urine problems passing urine bone, lower back ...

3 "Patients with bladder cancer need more effective treatment options that are both tolerable and easily incorporated into everyday practice, especially for those with HR-NMIBC, a highly recurrent ...

TAR-200 is a groundbreaking therapy for early-stage bladder cancer, designed to deliver a sustained local release of medication directly into the bladder—right where it is needed," said Biljana ...

“With these critical advancements, we are eager to connect, collaborate, and drive meaningful discussions with the urology community at AUA 2025, shaping the future of bladder and prostate ...

For example, emerging AI models are capable of not only measuring bladder volume but also identifying early signs of bladder cancer, interstitial cystitis, or neurogenic bladder dysfunction, enhancing ...